Predictmedix Inc. (PMED.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -36.87 Thousand CAD | 10.89% |
| 2022 | -41.38 Thousand CAD | 80.42% |
| 2021 | -211.3 Thousand CAD | 54.55% |
| 2020 | -464.86 Thousand CAD | 68.56% |
| 2019 | -1.47 Million CAD | 5.17% |
| 2018 | -1.55 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -28.79 Thousand CAD | 21.91% |
| 2024 Q2 | -6767.00 CAD | 76.5% |
| 2023 Q2 | -213.79 Thousand CAD | -3810.47% |
| 2023 Q3 | -44.43 Thousand CAD | 79.22% |
| 2023 Q1 | 5762.00 CAD | 113.92% |
| 2023 FY | -36.87 Thousand CAD | 10.89% |
| 2023 Q4 | -36.87 Thousand CAD | 17.01% |
| 2022 Q4 | -41.38 Thousand CAD | 61.4% |
| 2022 FY | -41.38 Thousand CAD | 80.42% |
| 2022 Q2 | -283.43 Thousand CAD | -802.09% |
| 2022 Q1 | -31.42 Thousand CAD | 85.13% |
| 2022 Q3 | -107.19 Thousand CAD | 62.18% |
| 2021 Q3 | -574.45 Thousand CAD | 51.3% |
| 2021 Q2 | -1.17 Million CAD | 30.67% |
| 2021 FY | -211.3 Thousand CAD | 54.55% |
| 2021 Q1 | -1.7 Million CAD | -254.41% |
| 2021 Q4 | -211.3 Thousand CAD | 63.22% |
| 2020 Q1 | -1.28 Million CAD | 13.24% |
| 2020 Q3 | -705.55 Thousand CAD | 23.33% |
| 2020 Q4 | -480.05 Thousand CAD | 31.96% |
| 2020 Q2 | -920.3 Thousand CAD | 28.25% |
| 2020 FY | -464.86 Thousand CAD | 68.56% |
| 2019 Q2 | -1.69 Million CAD | -208.71% |
| 2019 FY | -1.47 Million CAD | 5.17% |
| 2019 Q3 | -1.74 Million CAD | -3.18% |
| 2019 Q1 | 1.55 Million CAD | 200.0% |
| 2019 Q4 | -1.47 Million CAD | 15.46% |
| 2018 Q4 | -1.55 Million CAD | 0.0% |
| 2018 FY | -1.55 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aquarius Surgical Technologies Inc. | 682.6 Thousand CAD | 105.402% |
| Cannabix Technologies Inc. | -4.06 Million CAD | 99.092% |